References
Jankovic J, Tolosa E (2007) Parkinson`s disease and movement disorders. Lippincott Williams & Wilkins, Wolters Kluwer Business, Philadelphia
MIMS (web page). http://www.mims.com. Accessed 24 July 2014
Lipski J, Wan CK, Bai JZ, Pi R, Li D, Donnelly D (2007) Neuroprotective potential of ceftriaxone in in vitro models of stroke. Neuroscience 146:617–629
Kanai Y, Hediger MA (2003) The glutamate and neutral amino acid transporter family: physiological and pharmacological implications. Eur J Pharmacol 479:237–247
Fan X, Hughes KE, Jinnah HA, Hess EJ (2012) Selective and sustained α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor activation in cerebellum induces dystonia in mice. J Pharmacol Exp Ther 340:733–741
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tomic, S., Rotim, T., Hlavati, M. et al. Acute dystonic reaction associated with cefalexine. Neurol Sci 36, 1493–1494 (2015). https://doi.org/10.1007/s10072-015-2108-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-015-2108-2